首页|补阳还五汤合参芪地黄汤化裁调控VEGF-C/VEGFR3通路抑制淋巴管新生对糖尿病肾病小鼠的保护作用

补阳还五汤合参芪地黄汤化裁调控VEGF-C/VEGFR3通路抑制淋巴管新生对糖尿病肾病小鼠的保护作用

扫码查看
目的 基于调控VEGF-C/VEGFR3 通路抑制淋巴管新生探讨补阳还五汤合参芪地黄汤化裁对糖尿病肾病(DKD)小鼠的保护作用及机制.方法 将 24 只雄性db/db小鼠随机分为模型组、中药组(补阳还五汤合参芪地黄汤化裁,生药量 24.44 g·kg-1)和西药组(厄贝沙坦,13.5 mg·kg-1),每组 8 只,另外取 8 只db/m小鼠作为对照组.灌胃给药,每日 1 次,连续 12 周.检测小鼠血糖(FBG)、总胆固醇(TC)、甘油三脂(TG)、尿白蛋白/肌酐比值(ACR)及肾脏指数;采用HE、Masson染色法观察肾脏组织病理变化;免疫组化法检测肾脏组织纤连蛋白(FN)、Ⅰ型胶原蛋白(ColⅠ)、波形蛋白(Vimentin)、α平滑肌肌动蛋白(α-SMA)、转化生长因子β1(TGF-β1)、血管内皮生长因子受体 3(VEGFR3)、血管内皮生长因子C(VEGF-C)、淋巴管内皮透明质酸受体1(LYVE-1)、平足蛋白(PDPN)、肿瘤坏死因子α(TNF-α)和白细胞介素 1β(IL-1β)的表达;Western Blot法检测肾脏组织ColⅠ、Vimentin、α-SMA、TGF-β1、VEGFR3、VEGF-C、LYVE-1、TNF-α、IL-1β蛋白表达;Real-time PCR 法检测肾脏组织 FN、ColⅠ、TGF-β1、VEGF-C、VEGFR3、TNF-α、IL-1β mRNA 表达.结果 与对照组比较,模型组小鼠的血清FBG、TG、TC、ACR水平及肾脏指数均明显升高(P<0.05);肾小球肥大,系膜外基质增加,基底膜增厚,囊腔变窄,肾小管上皮细胞变性、坏死,间质有大量炎性细胞浸润,肾小管萎缩,纤维化水平明显升高(P<0.05);肾间质中 FN、ColⅠ、Vimentin、α-SMA、TGF-β1、VEGFR3、LYVE-1、TNF-α、IL-1β蛋白表达,胞质中VEGF-C蛋白表达及肾小管毛细血管周围VEGFR3、PDPN蛋白表达均明显上调(P<0.05);肾脏组织中ColⅠ、Vimentin、α-SMA、TGF-β1、VEGFR3、VEGF-C、LYVE-1、TNF-α、IL-1β 蛋白表达均明显上调(P<0.05);肾脏组织中 FN、ColⅠ、TGF-β1、VEGF-C、VEGFR3、TNF-α、IL-1β mRNA表达水平均明显升高(P<0.05).与模型组比较,中药组小鼠的血清TG、TC、ACR水平均明显降低(P<0.05);肾脏组织损伤有不同程度好转,炎性细胞浸润有一定程度减轻,纤维化水平明显降低(P<0.05);肾间质中FN、ColⅠ、Vimentin、α-SMA、TGF-β1、VEGFR3、LYVE-1、TNF-α、IL-1β蛋白表达,胞质中VEGF-C蛋白表达及肾小管毛细血管周围VEGFR3、PDPN蛋白表达均明显下调(P<0.05);肾脏组织中ColⅠ、Vimentin、α-SMA、TGF-β1、VEGFR3、VEGF-C、LYVE-1、TNF-α、IL-1β蛋白表达均明显下调(P<0.05);肾脏组织中FN、ColⅠ、TGF-β1、VEGF-C、VEGFR3、TNF-α、IL-1β mRNA表达水平均明显降低(P<0.05).结论 补阳还五汤合参芪地黄汤化裁可降低DKD小鼠肾脏组织炎症及纤维化水平,其机制可能与调控VEGF-C/VEGFR3 通路抑制淋巴管新生有关.
Study on the Protective Effect of Modified Buyang Huanwu Decoction and Shenqi Dihuang Decoction on Mice with Diabetic Kidney Disease by Regulating VEGF-C/VEGFR3 Pathway and Inhibiting Lymphangiogenesis
Objective To explore the protective effect and mechanism of modified Buyang Huanwu Decoction and Shenqi Dihuang Decoction on diabetic kidney disease(DKD)mice based on the regulation of VEGF-C/VEGFR3 pathway inhibiting lymphangiogenesis.Methods Twenty-four male db/db mice were randomly divided into model group,Chinese medicine group(modified Buyang Huanwu Decoction combined with Shenqi Dihuang Decoction,crude drug 24.44 g·kg-1)and western medicine group(Irbesartan,13.5 mg·kg-1),with eight mice in each group.Eight db/m mice were selected as control group.Intragastric administration was given once a day for 12 consecutive weeks.Fasting blood glucose(FBG),total cholesterol(TC),triglyceride(TG),urinary albumin/creatinine ratio(ACR)and kidney index were measured.The pathological changes of renal tissue were observed by HE and Masson staining.The expressions of fibronectin(FN),type I collagen(Col I),Vimentin,α-smooth muscle actin(α-SMA),transforming growth factor-β1(TGF-β1),vascular endothelial growth factor receptor 3(VEGFR3),vascular endothelial growth factor-C(VEGF-C),lymphatic endothelial hyaluronic acid receptor 1(LYVE-1),podoplanin(PDPN),tumor necrosis factor-α(TNF-α)and interleukin-1β(IL-1β)in renal tissue were detected by immunohistochemistry.The protein expressions of Col I,Vimentin,α-SMA,TGF-β1,VEGFR3,VEGF-C,LYVE-1,TNF-α and IL-1β in renal tissue were detected by Western Blot.The mRNA expressions of FN,Col I,TGF-β1,VEGF-C,VEGFR3,TNF-α and IL-1β in renal tissue were detected by Real-time PCR.Results Compared with the control group,the levels of serum FBG,TG,TC,ACR and kidney index in the model group were significantly increased(P<0.05).Glomerular hypertrophy,mesangial matrix increased,basement membrane thickening,cystic cavity narrowing,renal tubular epithelial cell degeneration and necrosis,interstitial infiltration of a large number of inflammatory cells,renal tubular atrophy;the level of renal fibrosis was significantly increased(P<0.05).The protein expressions of FN,Col I,Vimentin,α-SMA,TGF-β1,VEGFR3,LYVE-1,TNF-α,IL-1β in renal interstitium,the expression of VEGF-C protein in cytoplasm and the expression of VEGFR3 and PDPN protein around renal tubular capillaries were significantly up-regulated(P<0.05).The protein expressions of Col I,Vimentin,α-SMA,TGF-β1,VEGFR3,VEGF-C,LYVE-1,TNF-α and IL-1β in renal tissue were significantly up-regulated(P<0.05).The mRNA expression levels of FN,Col I,TGF-β1,VEGF-C,VEGFR3,TNF-α and IL-1β in renal tissue were significantly increased(P<0.05).Compared with the model group,the levels of serum TG,TC and ACR in the Chinese medicine group were significantly decreased(P<0.05).Renal tissue injury was improved to varying degrees,renal inflammatory cell infiltration was reduced to a certain extent,and renal tissue fibrosis was significantly reduced(P<0.05).The protein expressions of FN,Col I,Vimentin,α-SMA,TGF-β1,VEGFR3,LYVE-1,TNF-α,IL-1β in renal interstitium,the protein expression of VEGF-C in cytoplasm and the protein expressions of VEGFR3 and PDPN around renal tubular capillaries were significantly down-regulated(P<0.05).The protein expressions of Col I,Vimentin,α-SMA,TGF-β1,VEGFR3,VEGF-C,LYVE-1,TNF-α and IL-1β in renal tissue were significantly down-regulated(P<0.05).The mRNA expression levels of FN,Col I,TGF-β1,VEGF-C,VEGFR3,TNF-α and IL-1β in renal tissue were significantly decreased(P<0.05).Conclusion Modified Buyang Huanwu Decoction combined with Shenqi Dihuang Decoction can reduce the level of inflammation and fibrosis in renal tissue of DKD mice,and its mechanism may be related to the regulation of VEGF-C/VEGFR3 pathway to inhibit lymphangiogenesis.

modified Buyang Huanwu Decoction combining with Shenqi Dihuang Decoctiondiabetic kidney diseaseVEGF-C/VEGFR3 pathwaylymphangiogenesisinflammationfibrosismice

黄家安、张孟娟、杨帆、刘妍、王月华

展开 >

河北中医药大学,河北 石家庄 050200

河北省中西医结合肝肾病证研究重点实验室,河北 石家庄 050091

河北中医药大学中西医结合研究所,河北石家庄 050091

补阳还五汤合参芪地黄汤化裁 糖尿病肾病 VEGF-C/VEGFR3通路 淋巴管新生 炎症 纤维化 小鼠

河北省自然科学基金河北省教育厅重点项目河北省重点研发计划中医药创新专项

H2022423342ZD202108122377715OD

2024

中药新药与临床药理
广州中医药大学

中药新药与临床药理

CSTPCD北大核心
影响因子:0.908
ISSN:1003-9783
年,卷(期):2024.35(6)
  • 5